In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
March 10th, 2009 | 23 | Yes |
Popular Name: 4-Piperidinamine, 4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)- 4-Piperidinamine, 4-(4-chlorophe…
Find On: PubMed — Wikipedia — Google
CAS Number: 885499-69-4
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.92 | 7.24 | -55.9 | 4 | 5 | 1 | 72 | 328.827 | 2 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AKT2-2-E | Serine/threonine-protein Kinase AKT2 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 7 | 0.50 | Binding ≤ 10μM |
GSK3B-1-E | Glycogen Synthase Kinase-3 Beta (cluster #1 Of 7), Eukaryotic | Eukaryotes | 600 | 0.38 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 1000 | 0.37 | Binding ≤ 1μM |
AKT2_HUMAN | P31751 | Serine/threonine-protein Kinase AKT2, Human | 7 | 0.50 | Binding ≤ 1μM |
GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 1000 | 0.37 | Binding ≤ 10μM |
AKT2_HUMAN | P31751 | Serine/threonine-protein Kinase AKT2, Human | 7 | 0.50 | Binding ≤ 10μM |
Description | Species |
---|---|
Activation of BAD and translocation to mitochondria | |
Activation of PKB | |
AKT phosphorylates targets in the cytosol | |
AKT phosphorylates targets in the nucleus | |
AKT-mediated inactivation of FOXO1A | |
APC truncation mutants have impaired AXIN binding | |
AXIN missense mutants destabilize the destruction complex | |
Beta-catenin phosphorylation cascade | |
CD28 dependent PI3K/Akt signaling | |
Constitutive PI3K/AKT Signaling in Cancer | |
CRMPs in Sema3A signaling | |
CTLA4 inhibitory signaling | |
deactivation of the beta-catenin transactivating complex | |
Degradation of beta-catenin by the destruction complex | |
disassembly of the destruction complex and recruitment of AXIN to the membrane | |
Downregulation of ERBB2:ERBB3 signaling | |
G beta:gamma signalling through PI3Kgamma | |
GPVI-mediated activation cascade | |
Inhibition of TSC complex formation by PKB | |
misspliced GSK3beta mutants stabilize beta-catenin | |
Negative regulation of the PI3K/AKT network | |
PDE3B signalling | |
PIP3 activates AKT signaling | |
Regulation of HSF1-mediated heat shock response | |
S33 mutants of beta-catenin aren't phosphorylated | |
S37 mutants of beta-catenin aren't phosphorylated | |
S45 mutants of beta-catenin aren't phosphorylated | |
T41 mutants of beta-catenin aren't phosphorylated | |
Translocation of GLUT4 to the plasma membrane | |
truncations of AMER1 destabilize the destruction complex | |
VEGFR2 mediated vascular permeability |